Click for best price
Acute Agitation Aggression Drugs Market Size, Share 2023
With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas.
This report aims to provide a comprehensive presentation of the global market for Acute Agitation and Aggression Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Agitation and Aggression Drugs. This report contains market size and forecasts of Acute Agitation and Aggression Drugs in global, including the following market information:
Global Acute Agitation and Aggression Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Acute Agitation and Aggression Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acute Agitation and Aggression Drugs include Eli Lilly and Company, Pfizer, Ono Pharmaceutical, Otsuka Holdings, GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson and H. Lundbeck A/S, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acute Agitation and Aggression Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Agitation and Aggression Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Acute Agitation and Aggression Drugs Market Segment Percentages, by Type, 2022 (%)
Oral
Intramuscular Injection
Others
Global Acute Agitation and Aggression Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Acute Agitation and Aggression Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals & Ambulatory Surgical Centers
Psychiatric Care Facilities
Others
Global Acute Agitation and Aggression Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Acute Agitation and Aggression Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Agitation and Aggression Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Acute Agitation and Aggression Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company
Pfizer
Ono Pharmaceutical
Otsuka Holdings
GlaxoSmithKline
Bristol-Myers Squibb
Johnson & Johnson
H. Lundbeck A/S
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Agitation and Aggression Drugs, market overview.
Chapter 2: Global Acute Agitation and Aggression Drugs market size in revenue.
Chapter 3: Detailed analysis of Acute Agitation and Aggression Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Agitation and Aggression Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Acute Agitation and Aggression Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Acute Agitation and Aggression Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Agitation and Aggression Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Agitation and Aggression Drugs Overall Market Size
2.1 Global Acute Agitation and Aggression Drugs Market Size: 2022 VS 2030
2.2 Global Acute Agitation and Aggression Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Agitation and Aggression Drugs Players in Global Market
3.2 Top Global Acute Agitation and Aggression Drugs Companies Ranked by Revenue
3.3 Global Acute Agitation and Aggression Drugs Revenue by Companies
3.4 Top 3 and Top 5 Acute Agitation and Aggression Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Agitation and Aggression Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Agitation and Aggression Drugs Players in Global Market
3.6.1 List of Global Tier 1 Acute Agitation and Aggression Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Agitation and Aggression Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Agitation and Aggression Drugs Market Size Markets, 2022 & 2030
4.1.2 Oral
4.1.3 Intramuscular Injection
4.1.4 Others
4.2 By Type - Global Acute Agitation and Aggression Drugs Revenue & Forecasts
4.2.1 By Type - Global Acute Agitation and Aggression Drugs Revenue, 2018-2023
4.2.2 By Type - Global Acute Agitation and Aggression Drugs Revenue, 2024-2030
4.2.3 By Type - Global Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Agitation and Aggression Drugs Market Size, 2022 & 2030
5.1.2 Hospitals & Ambulatory Surgical Centers
5.1.3 Psychiatric Care Facilities
5.1.4 Others
5.2 By Application - Global Acute Agitation and Aggression Drugs Revenue & Forecasts
5.2.1 By Application - Global Acute Agitation and Aggression Drugs Revenue, 2018-2023
5.2.2 By Application - Global Acute Agitation and Aggression Drugs Revenue, 2024-2030
5.2.3 By Application - Global Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Acute Agitation and Aggression Drugs Market Size, 2022 & 2030
6.2 By Region - Global Acute Agitation and Aggression Drugs Revenue & Forecasts
6.2.1 By Region - Global Acute Agitation and Aggression Drugs Revenue, 2018-2023
6.2.2 By Region - Global Acute Agitation and Aggression Drugs Revenue, 2024-2030
6.2.3 By Region - Global Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Acute Agitation and Aggression Drugs Revenue, 2018-2030
6.3.2 US Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.3.3 Canada Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.3.4 Mexico Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Acute Agitation and Aggression Drugs Revenue, 2018-2030
6.4.2 Germany Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.4.3 France Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.4.4 U.K. Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.4.5 Italy Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.4.6 Russia Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.4.8 Benelux Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Acute Agitation and Aggression Drugs Revenue, 2018-2030
6.5.2 China Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.5.3 Japan Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.5.4 South Korea Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.5.6 India Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Acute Agitation and Aggression Drugs Revenue, 2018-2030
6.6.2 Brazil Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.6.3 Argentina Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Agitation and Aggression Drugs Revenue, 2018-2030
6.7.2 Turkey Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.7.3 Israel Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Acute Agitation and Aggression Drugs Market Size, 2018-2030
6.7.5 UAE Acute Agitation and Aggression Drugs Market Size, 2018-2030
7 Acute Agitation and Aggression Drugs Companies Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Company Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Acute Agitation and Aggression Drugs Major Product Offerings
7.1.4 Eli Lilly and Company Acute Agitation and Aggression Drugs Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly and Company Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Acute Agitation and Aggression Drugs Major Product Offerings
7.2.4 Pfizer Acute Agitation and Aggression Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Ono Pharmaceutical
7.3.1 Ono Pharmaceutical Company Summary
7.3.2 Ono Pharmaceutical Business Overview
7.3.3 Ono Pharmaceutical Acute Agitation and Aggression Drugs Major Product Offerings
7.3.4 Ono Pharmaceutical Acute Agitation and Aggression Drugs Revenue in Global Market (2018-2023)
7.3.5 Ono Pharmaceutical Key News & Latest Developments
7.4 Otsuka Holdings
7.4.1 Otsuka Holdings Company Summary
7.4.2 Otsuka Holdings Business Overview
7.4.3 Otsuka Holdings Acute Agitation and Aggression Drugs Major Product Offerings
7.4.4 Otsuka Holdings Acute Agitation and Aggression Drugs Revenue in Global Market (2018-2023)
7.4.5 Otsuka Holdings Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Acute Agitation and Aggression Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Acute Agitation and Aggression Drugs Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Acute Agitation and Aggression Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Acute Agitation and Aggression Drugs Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Acute Agitation and Aggression Drugs Major Product Offerings
7.7.4 Johnson & Johnson Acute Agitation and Aggression Drugs Revenue in Global Market (2018-2023)
7.7.5 Johnson & Johnson Key News & Latest Developments
7.8 H. Lundbeck A/S
7.8.1 H. Lundbeck A/S Company Summary
7.8.2 H. Lundbeck A/S Business Overview
7.8.3 H. Lundbeck A/S Acute Agitation and Aggression Drugs Major Product Offerings
7.8.4 H. Lundbeck A/S Acute Agitation and Aggression Drugs Revenue in Global Market (2018-2023)
7.8.5 H. Lundbeck A/S Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Acute Agitation and Aggression Drugs Market Opportunities & Trends in Global Market
Table 2. Acute Agitation and Aggression Drugs Market Drivers in Global Market
Table 3. Acute Agitation and Aggression Drugs Market Restraints in Global Market
Table 4. Key Players of Acute Agitation and Aggression Drugs in Global Market
Table 5. Top Acute Agitation and Aggression Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Acute Agitation and Aggression Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Acute Agitation and Aggression Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Acute Agitation and Aggression Drugs Product Type
Table 9. List of Global Tier 1 Acute Agitation and Aggression Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Agitation and Aggression Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Acute Agitation and Aggression Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Acute Agitation and Aggression Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Acute Agitation and Aggression Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Acute Agitation and Aggression Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Acute Agitation and Aggression Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Acute Agitation and Aggression Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Eli Lilly and Company Company Summary
Table 31. Eli Lilly and Company Acute Agitation and Aggression Drugs Product Offerings
Table 32. Eli Lilly and Company Acute Agitation and Aggression Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Eli Lilly and Company Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Acute Agitation and Aggression Drugs Product Offerings
Table 36. Pfizer Acute Agitation and Aggression Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Ono Pharmaceutical Company Summary
Table 39. Ono Pharmaceutical Acute Agitation and Aggression Drugs Product Offerings
Table 40. Ono Pharmaceutical Acute Agitation and Aggression Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Ono Pharmaceutical Key News & Latest Developments
Table 42. Otsuka Holdings Company Summary
Table 43. Otsuka Holdings Acute Agitation and Aggression Drugs Product Offerings
Table 44. Otsuka Holdings Acute Agitation and Aggression Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Otsuka Holdings Key News & Latest Developments
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Acute Agitation and Aggression Drugs Product Offerings
Table 48. GlaxoSmithKline Acute Agitation and Aggression Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Acute Agitation and Aggression Drugs Product Offerings
Table 52. Bristol-Myers Squibb Acute Agitation and Aggression Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Acute Agitation and Aggression Drugs Product Offerings
Table 56. Johnson & Johnson Acute Agitation and Aggression Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. H. Lundbeck A/S Company Summary
Table 59. H. Lundbeck A/S Acute Agitation and Aggression Drugs Product Offerings
Table 60. H. Lundbeck A/S Acute Agitation and Aggression Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. H. Lundbeck A/S Key News & Latest Developments
List of Figures
Figure 1. Acute Agitation and Aggression Drugs Segment by Type in 2022
Figure 2. Acute Agitation and Aggression Drugs Segment by Application in 2022
Figure 3. Global Acute Agitation and Aggression Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Agitation and Aggression Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Acute Agitation and Aggression Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Agitation and Aggression Drugs Revenue in 2022
Figure 8. By Type - Global Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 16. US Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 28. China Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Acute Agitation and Aggression Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Acute Agitation and Aggression Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Eli Lilly and Company Acute Agitation and Aggression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Acute Agitation and Aggression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ono Pharmaceutical Acute Agitation and Aggression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Otsuka Holdings Acute Agitation and Aggression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithKline Acute Agitation and Aggression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Bristol-Myers Squibb Acute Agitation and Aggression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Johnson & Johnson Acute Agitation and Aggression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. H. Lundbeck A/S Acute Agitation and Aggression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
